UC Merced |

Cancer cell growth linked to nervous system in UC Merced study

Research shows cells with damaged DNA proliferate more in upper areas of the body and near brain tissue in flatworms.

UC San Francisco |

Laura Esserman named to TIME 100 list

UCSF oncologist at the forefront of breast cancer services named one of the most influential people in the world.

UC San Francisco |

UCSF cancer immunotherapy clinic offers unique studies of promising treatments

Cutting-edge therapies are helping patients keep cancer in check for years.

UCLA |

Microscope uses artificial intelligence to find cancer cells more efficiently

UCLA-invented device analyzes 36 million images per second and uses deep learning to identify rogue cells.

UC San Francisco |

UCSF, UCLA join collaboration to advance national cancer initiative

Renowned UCSF immunologist to head new Parker Institute for Cancer Immunotherapy.

UCLA |

UCLA study yields the key to effective personalized medicine

New platform optimizes drug doses to prevent organ rejection for transplant patients.

UC San Diego |

Higher levels of vitamin D correspond to lower cancer risk

Levels of 40 ng/ml or greater can make the disease as much as 67 percent less likely, UC San Diego researchers find.

UC Davis |

Cancer gene twice as likely to be defective in children with autism

A tumor suppressor is found missing in many autistic children and their fathers by UC Davis researchers.

UC Santa Cruz Magazine |

Building a ladder to a cure

UC Santa Cruz researchers open a new front in the treatment of pediatric cancer.

UC Newsroom |

Stem cell grants to help fight rare diseases affecting children

UC researchers from four campuses receive five grants totaling more than $21 million in funding.

UC Riverside |

Thirdhand smoke linked to Type 2 diabetes

UC Riverside and UCSF study has health implications for nonsmokers living in homes that have (or had) smokers.

UC Merced |

UC Merced researchers identify drug that could treat melanoma

Scientists discover a genetic activation among patients with skin cancer that could be suppressed by a new drug.